Zewei Wang

12PUBLICATIONS

15CO-AUTHORS

Predictive and prognostic markersHaematological tumoursCancer cell biologyMolecular targetsTumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jun 29, 2026

Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma.

|May 20, 2026

Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma.

|May 15, 2026

Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpression.

|Dec 10, 2025

Natural killer cell infiltration elicits gender-dependent dichotomous clinical outcomes in urothelial carcinoma.

Lingkai Zhang, Zhaopei Liu, Yawei Ding

|Aug 11, 2025

ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma.

Zhaopei Liu, Lingkai Zhang, Kaifeng Jin

|Jan 06, 2025

Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression.

Kaifeng Jin, Yawei Ding, Jingtong Xu

Pageof 2

Frequent Collaborators

11 joint publications

Kaifeng Jin

10 joint publications

Jiejie Xu

10 joint publications

Zhaopei Liu

Han Zeng

Weijuan Zhang

Yu Zhu

Lingkai Zhang

Xiaohe Su

Yawei Ding

Jiaxing Sun

Frequent Collaborators

11 joint publications

Kaifeng Jin

10 joint publications

Jiejie Xu

10 joint publications

Zhaopei Liu

9 joint publications

Han Zeng